國家商務部:65個世貿組織成員代表對內地積極評價
國家商務部副部長兼國際貿易談判副代表王受文介紹世貿組織第八次對華貿易政策審議情況時表示,此次審議,共有65個世貿組織成員代表在會上發言,成員對內地的積極評價體現在多個方面,包括肯定中方積極參與世貿組織工作,認真履行加入承諾,積極參與漁業補貼談判,積極引領投資便利化談判,建設性參與電子商務談判;高度評價內地在國際抗疫合作中發揮的重要作用;感謝內地給予最不發達國家「雙免」待遇;充分肯定中方主動降低關稅和壓減外資準入負面清單,不斷擴大市場準入;積極評價「一帶一路」倡議在促進相關國家貿易經濟合作方面具有巨大潛力。(ta/k) ~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.